Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

Presentation TCT 2023

Where Do Antithrombotics Fit In?

Presenter: Marc Bonaca

October 26, 2023

Presentation TCT 2023

Optimal Antithrombotic Strategies in MCS Use

Presenter: Mirvat Alasnag

October 26, 2023

Presentation TCT 2023

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

Presenter: Manasi Tannu

October 26, 2023

Presentation TCT 2023

Case Resolution: Long-term Therapy

Presenter: NULL

October 25, 2023

Presentation TCT 2023

The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient

Presenter: John Bittl

October 25, 2023

Presentation TCT 2023

Longer Term DAPT Is What The Guidelines and Data Support

Presenter: Mamas Mamas

October 25, 2023

Presentation TCT 2023

Case Continuation: In Hospital Management

Presenter: Davide Cao

October 25, 2023

Presentation TCT 2023

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Presenter: Michael Savage

October 25, 2023

Presentation TCT 2023

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Presenter: Jennifer Rymer

October 25, 2023

$Unfractionated Heparin Still Works for Primary PCI!$

Presentation TCT 2023

Unfractionated Heparin Still Works for Primary PCI!

Presenter: Rod Stables

October 25, 2023

Presentation TCT 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presenter: Gregg Stone

October 25, 2023

Presentation TCT 2023

Case Presentation

Presenter: Davide Cao

October 25, 2023

Presentation TCT 2023

What’s Next in Antithrombotic Therapy?

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

Aspirin or Clopidogrel for Chronic Management?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

DAPT After PCI: Do We Need It at All?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

DAPT Duration: Unsettled or Case Closed?

Presenter: Duk-Woo Park

October 24, 2023

Presentation TCT 2023

Guided Antiplatelet Therapy: Why, and in Whom?

Presenter: Jurrien Ten Berg

October 24, 2023

Presentation TCT 2023

Standardizing The Language Around DAPT: An ARC Initiative

Presenter: Davide Capodanno

October 24, 2023

Presentation TCT 2023

A Typical PCI Case in 2023 with Longitudinal Follow Up

Presenter: Mahesh Madhavan

October 24, 2023

Advertisement

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Where Do Antithrombotics Fit In?

Optimal Antithrombotic Strategies in MCS Use

TCT 406: Effect of Antithrombotic Strategies on Total Outcome Events in Patients with Atrial Fibrillation after Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS

Case Resolution: Long-term Therapy

The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient

Longer Term DAPT Is What The Guidelines and Data Support

Case Continuation: In Hospital Management

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Unfractionated Heparin Still Works for Primary PCI!

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Case Presentation

What’s Next in Antithrombotic Therapy?

Aspirin or Clopidogrel for Chronic Management?

DAPT After PCI: Do We Need It at All?

DAPT Duration: Unsettled or Case Closed?

Guided Antiplatelet Therapy: Why, and in Whom?

Standardizing The Language Around DAPT: An ARC Initiative

A Typical PCI Case in 2023 with Longitudinal Follow Up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content